Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBIOX vs BIB overlap: 30% of top holdings shared

Bottom line

How much do FBIOX and BIB overlap?

30% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 24.5% of FBIOX's assets and 18.5% of BIB's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

FBIOXBIB
Weight overlap (top 25)30%
Shared holdings9
Weight in shared holdings24.5%18.5%
Total positions215267
Expense ratio0.62%0.95%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings FBIOX and BIB have in common

Holding% of FBIOX% of BIBOverlap
Amgen Inc6.53%4.48%4.48%
Gilead Sciences Inc4.82%4.66%4.66%
Alnylam Pharmaceuticals Inc2.93%2.01%2.01%
Insmed Inc2.25%1.16%1.16%
Argenx Se2.25%1.19%1.19%
Revolution Medicines Inc2.02%1.57%1.57%
Moderna Inc1.28%0.94%0.94%
Biogen Inc1.26%1.44%1.26%
Roivant Sciences Ltd1.13%1.08%1.08%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBIOX

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Fidelity Revere Street Trust — 3.35%
  4. Praxis Precision Medicines Inc. — 2.47%
  5. Ascendis Pharma A/s — 2.04%
  6. Ucb Sa — 2.00%
  7. Jazz Pharmaceuticals Plc — 1.84%
  8. Scholar Rock Holding Corp — 1.55%
  9. Natera Inc — 1.41%
  10. Axsome Therapeutics Inc — 1.28%
  11. Protagonist Therapeutics Inc — 1.15%
  12. Cogent Biosciences Inc — 1.07%
  13. Tango Therapeutics Inc — 0.98%
  14. Celcuity Inc — 0.95%
  15. Madrigal Pharmaceuticals Inc — 0.93%

Only in BIB

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. Vertex Pharmaceuticals, Inc. — 4.65%
  4. N/a — 3.94%
  5. N/a — 3.26%
  6. Regeneron Pharmaceuticals, Inc. — 3.21%
  7. N/a — 2.62%
  8. Repurchase Agreement — 1.28%
  9. Illumina, Inc. — 1.25%
  10. United Therapeutics Corp. — 1.22%
  11. Royalty Pharma plc — 1.20%
  12. N/a — 1.18%
  13. Incyte Corp. — 0.97%
  14. Viatris, Inc. — 0.94%
  15. Guardant Health, Inc. — 0.85%

Asset mix

Asset typeFBIOXBIB
Stocks99.0%63.0%
Equity derivatives—16.0%
Other—6.8%
Cash & short-term funds3.5%0.8%
Repurchase agreements—3.1%
Preferred stock0.9%—

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryFBIOXBIB
US88.5%79.8%
NL2.9%1.6%
DK2.6%0.8%
BE2.0%—
IE2.0%1.2%
GB0.8%1.7%
BM1.1%1.1%
CH1.1%0.8%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FBIOX and BIB overlap?
About 30% by weight. 9 securities appear in both funds' top 25 holdings; they make up 24.5% of FBIOX's assets and 18.5% of BIB's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do FBIOX and BIB have in common?
The largest shared holdings are Gilead Sciences Inc, Amgen Inc, Alnylam Pharmaceuticals Inc, Revolution Medicines Inc, Biogen Inc.
Should I own both FBIOX and BIB?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, FBIOX or BIB?
BIB is broader, with 267 positions versus 215 for FBIOX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.